Shares in Aortech International, the developer of a polymer for medical devices, fell following the announcement that it is in dispute with its largest customer, St Jude Medical.
The dispute centres around the use that St Jude Medical is making of Optim, which is actually Elasteon supplied by Aortech. Aortech alleges that there has been a "material breach of contract" by St Jude Medical.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It is the latest blow in a long-running saga that has given investors a white knuckle ride over the past year, during which its share price hit a high of 371p before plummeting.
In late September, Aortech's shares halved after warning that takeover talks had collapsed and that it was investigating funding options.
CM
-
David Ellison: America's new media mogulDavid Ellison is building a mighty new force in old and new media. Critics worry that he will prove to be a Trumpian patsy. Is that fair?
-
Investors have overlooked some of China’s best growth stocksOpinion Dale Nicholls, portfolio manager, Fidelity China Special Situations, highlights three Chinese businesses where he’d put his money
